As of 30 Sep 2025, 1 institutional investors reported holding 1 shares of GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 1 | $68 | $68.00 | 1 | |
| 2025 Q2 | 1 | $68 | $68.00 | 1 | |
| 2025 Q1 | 1 | $68 | $68.00 | 1 | |
| 2024 Q4 | 1 | $68 | $68.00 | 1 | |
| 2024 Q3 | 1 | $68 | $68.00 | 1 | |
| 2024 Q2 | 1 | $68 | $68.00 | 1 | |
| 2024 Q1 | 1 | $68 | $68.00 | 1 | |
| 2023 Q4 | 1 | $68 | $68.00 | 1 | |
| 2023 Q3 | 1 | $68 | $68.00 | 1 | |
| 2023 Q2 | 1 | $68 | $68.00 | 1 | |
| 2023 Q1 | 1 | $68 | -$42,000 | $68.00 | 1 |
| 2022 Q4 | 622 | $42,068 | -$4,636,555,323 | $67.82 | 2 |
| 2022 Q3 | 68,603,587 | $4,671,894,132 | +$222,754,372 | $68.10 | 234 |
| 2022 Q2 | 71,549,278 | $2,286,165,853 | +$32,287,189 | $31.95 | 188 |
| 2022 Q1 | 70,473,246 | $2,440,721,615 | +$203,150,884 | $34.64 | 197 |
| 2021 Q4 | 65,380,834 | $1,912,992,806 | +$28,389,702 | $29.27 | 197 |
| 2021 Q3 | 60,521,706 | $1,542,631,378 | -$101,340,803 | $25.48 | 179 |
| 2021 Q2 | 65,071,757 | $2,278,570,190 | -$60,091,831 | $35.02 | 183 |
| 2021 Q1 | 66,376,546 | $2,701,410,933 | +$72,338,257 | $40.75 | 203 |
| 2020 Q4 | 64,360,583 | $2,787,563,353 | -$81,073,350 | $43.31 | 217 |
| 2020 Q3 | 64,197,888 | $3,539,139,123 | -$54,346,929 | $55.14 | 223 |
| 2020 Q2 | 64,773,617 | $4,100,703,173 | +$3,091,735 | $63.13 | 242 |
| 2020 Q1 | 65,071,284 | $3,324,000,840 | +$213,466,169 | $51.09 | 208 |
| 2019 Q4 | 59,529,732 | $4,731,978,584 | +$24,205,497 | $79.49 | 229 |
| 2019 Q3 | 59,954,354 | $2,909,347,529 | +$23,297,918 | $48.52 | 200 |
| 2019 Q2 | 59,490,714 | $3,129,967,197 | +$84,209,548 | $52.60 | 218 |
| 2019 Q1 | 57,985,184 | $3,068,971,574 | +$72,489,220 | $52.93 | 196 |
| 2018 Q4 | 56,883,123 | $2,334,880,874 | +$149,348,457 | $41.05 | 188 |
| 2018 Q3 | 53,139,588 | $2,019,324,810 | +$29,127,676 | $38.00 | 181 |
| 2018 Q2 | 51,596,963 | $2,332,359,618 | +$84,653,893 | $45.20 | 194 |
| 2018 Q1 | 49,834,317 | $2,407,032,328 | +$327,784,015 | $48.30 | 172 |
| 2017 Q4 | 43,408,410 | $1,708,265,529 | +$165,160,347 | $39.35 | 155 |
| 2017 Q3 | 39,428,282 | $1,223,815,787 | +$64,487,207 | $31.05 | 134 |
| 2017 Q2 | 37,609,783 | $1,028,623,485 | +$172,984,509 | $27.35 | 134 |
| 2017 Q1 | 31,360,806 | $1,155,631,753 | +$338,516,699 | $36.85 | 117 |
| 2016 Q4 | 25,414,298 | $367,222,655 | +$55,618,026 | $14.45 | 95 |
| 2016 Q3 | 20,941,617 | $482,311,923 | -$39,648,327 | $23.05 | 83 |
| 2016 Q2 | 23,425,328 | $388,553,133 | +$148,855,829 | $16.59 | 93 |
| 2016 Q1 | 14,519,063 | $230,180,808 | -$18,475,024 | $15.86 | 75 |
| 2015 Q4 | 14,348,669 | $463,905,724 | +$65,475,499 | $32.33 | 67 |
| 2015 Q3 | 26,555,317 | $1,118,824,007 | +$1,118,824,003 | $42.16 | 58 |